Skip to main content
| Hans-Günter Meyer-Thompson | Ukraine

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study. 

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study. 

Korotych O, Achar J, Gurbanova E, Hovhannesyan A, Lomtadze N, Ciobanu A, Skrahina A, Dravniece G, Kuksa L, Rich M, Khachatryan N, Germanovych M, Kadyrov A, Terleieva I, Akhundova I, Adenov M, Durdyeva M, Kiria N, Parpieva N, Yatskevich N, Jumayev R, Nurov R, Diktanas S, Vilc V, Migliori GB, Yedilbayev A.

Lancet Infect Dis. 2024 Jun 13:S1473-3099(24)00228-7. doi: 10.1016/S1473-3099(24)00228-7. Epub ahead of print. PMID: 38880112.

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00228-7/fulltexthttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00228-7/fulltext